Top Markets
#1 Akedo Akedo +136.52%
#2 TENDIES TENDIES +87.88%
#3 Verus Coin Verus Coin +43.84%
#4 Threshold Network Threshold Network +43.74%
#5 Bitway Bitway +27.02%
#6 Mubarak Mubarak +25.52%
#7 Cash Cat Cash Cat +23.53%
#8 Palladium Network Palladium Network +22.71%
#9 MultiversX MultiversX +20.20%
#10 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Regulus Therapeutics Inc. Regulus Therapeutics Inc.

Regulus Therapeutics Inc.

RGLS
Classement en actions #17600
Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development... Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States. Its current pipeline highlights RG-012, an anti-miR compound engineered to inhibit miR-21, which is currently in a Phase II clinical study for Alport syndrome, a severe renal condition. Another significant candidate, RGLS8429, an anti-miR agent targeting miR-17, is being evaluated in a Phase 1b clinical trial for autosomal dominant polycystic kidney disease. Beyond these clinical programs, Regulus is also cultivating an extensive preclinical portfolio, emphasizing drug candidates with precise, organ-selective delivery strategies. The company was established in 2007.
Prix de l'action
$8.16
Dernière synchronisation: 2025-06-26
Capitalisation boursière
$234.57M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Regulus Therapeutics Inc. (RGLS)

Catégorie

Healthcare
Historique du prix de l'action pour Regulus Therapeutics Inc. (RGLS)
Prix de clôture le plus élevé : $8.13 le 2025-06-01

Prix de clôture le plus bas : $542.40 le 2012-10-01
Historique du prix de l'action de Regulus Therapeutics Inc. de 2012 à 2026
Performance annuelle du prix de l'action
Année Performance
2025 412.85%
2024 18.41%
2023 -5.90%
2022 -59.58%
2021 -68.07%
2020 52.53%
2019 -42.38%
2018 -88.97%
2017 -61.61%
2016 -73.01%
2015 -43.68%
2014 142.24%
2013 35.08%
2012 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $556.43 38.76%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.60%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $152.82 531.75%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.71 8.20%
CH